T 0369/11 (Use of cabazitaxel for treating glioblastoma/AVENTIS) of 15.09.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T036911.20140915
- Date of decision
- 15 September 2014
- Case number
- T 0369/11
- Online on
- 18 September 2014
- Petition for review of
- -
- Application number
- 99944531.5
- IPC class
- A61K 31/335
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NEW USE OF TAXOID DERIVATIVES
- Applicant name
- Aventis Pharma S.A.
- Opponent name
- -
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 123(2)
- Keywords
- New main request at appeal proceedings: allowable (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to grant a patent on the basis of the main request (single claim) filed as auxiliary request with the letter of 19 June 2014, and a description to be adapted.